Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
2021 · The Lancet Oncology · 250 citations
https://doi.org/10.1016/s1470-2045(20)30642-2
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
32
Papers
406
Citations
5
h-index
5
i10-index
Magdalena Schwarz is an academic researcher from GlaxoSmithKline (Belgium). The author has contributed to research in topics: Taxation and Legal Issues & Herpesvirus Infections and Treatments & Corporate Taxation and Avoidance. The author has an h-index of 5, co-authored 28 publications.
ORCID: 0000-0002-4850-8597https://doi.org/10.1016/s1470-2045(20)30642-2
https://doi.org/10.1007/s13555-021-00535-7
https://doi.org/10.1007/s40121-021-00573-w
https://doi.org/10.1007/s40121-025-01118-1
Click to start Chat